PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity
a Key Laboratory of Structure-Based Drug Design & Discovery, Wuya College of Innovation, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
b Fujian Key Laboratory of Chinese Materia Medica, Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
c School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
收起